Measurement of plasma 25(OH)-vitamin D (250HD) is the accepted index of vitamin D status for people with normal vitamin D metabolism. 1 Although several assay methods for plasma 250HD, based on high-performance liquid chromatography, or Sephadex separations combined with competitive protein binding have been reported, there remains a need for a well-characterized, widely accepted procedure which has a high potential throughput, and long-term reliability. This report describes the precision and long-term reliability of a commercial kit assay during a survey of 737 British children aged 1·5 to 4·5 years, over a period of 1 year. 2 Population survey work in particular, requires precise measurements in both the normal and subnormal ranges; freedom from long-term drift, and freedom from stepwise changes in sensitivity.
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The commercial kit assay used was that based on the procedure of Hollis et al., 3 and marketed by Incstar Corporation (Stillwater, Minnesota, USA). It employs a specific antibody, raised in goats against a 250HD derivative, and a radiolabelled 250HD as tracer, which was originally 3H, but now uses 1251. For convenience, each kit was subdivided into two runs, for I day's work. In each assay 12 unknowns were analysed in duplicate and a set of control sera were placed at the beginning and at the end. The assay was performed according to manufacturer's instructions except that two separate aliquots of standard plasma (or QC) sample were extracted and assayed once, instead of performing a single extraction to generate two measurements, as suggested in the instructions. Radioactivity estimation and data-reduction were performed with a Wallac (Turku, Finland) Wizard -y-counter, Correspondence; Dr C J Bates. with a lO-sample turret and a Multicalc (Wallac) programme, based on a spline data-fit. Quality control samples used in the present study comprised: (a) the serum-like QC sample, provided with the kit, with an assigned range of values near the lower limit of the reference range; (b) a BioRad Lyphochek control serum; (c) an in-house heparinized plasma pool from healthy human subjects, stored in small aliquots at -85°C. The QC sample provided in the kit was not suitable for long-term quality assurance, being nonidentical between kit batches. The in-house QC sample most closely resembled the samples from the survey, and was therefore most suitable for long-term quality assurance. Enough QC material for each days' work was thawed at the beginning of the day, kept on ice, and then discarded. Table 1 shows the precision results. The observed within batch coefficient of variation (CV) of 70/0 was similar to the manufacturers' guide values of 5-7%. It was stable throughout the survey. Comparing the two batches that were run during each working day, there was a small but directionally consistent difference in observed QC values, whose origin is unknown. Between assay precision, shown in Table 1 , were consistently better than the manufacturers' guideline.
The possibility of drift over time was analysed by linear regression against assay number. A small but significant upward drift was present for the kit and the in-house QC materials (r= +0·629 and r= +0·563 respectively; n=45, P<O·OOI), and a positive trend not reaching significance (r= +0·288, P>0·05) was observed for the Lyphochek QC. It is possible, but not likely, that a change in concentration of 250HD in the stored QC samples occurred during storage in -80°C. The drift (+ 5 to + 8 nmol/L over 16 months) was much less than the seasonal variations in mean population values, and was thus of minor practical importance, however, it will need to be monitored in future series. Batch-analysis of the samples, with a single batch of kits, may overcome this problem. However, this was not feasible during the survey described, because clinically abnormal values had to be reported within 3 months. During this survey, 18 different batch numbers of kits were used, with eight different lots of standards and control sera. Percentage binding of the radio-activity in the zero standard varied from about 480/0 near the beginning of the series, to about 30% towards the end, but as noted above, the variation in the measured QC values was much smaller.
TABLE I. Within-and between-run precision, and comparison with assigned values for quality control (QC) samples, in the Incstar 25(OH)-vitamin D assay. Within each run, each control sample generated four values: two adjacent values near the start and two adjacent values near the end, ofeach run. For the within-run CV calculation the mean was taken for the first pair and the mean for the second pair. The CV was calculated from the difference between those two means. This was considered to be a 'worst case' scenario with respect to drift during the run, but to be a realistic reflection of the fact that each unknown was analysed as adjacent duplicates, and the mean calculated. Each result was obtained from a separate acetonitrile extraction
The 97· 5% range of values observed in the National Diet and Nutrition Survey of pre-school British children? was 30 to 100 nmol/L (mean of 68· 1 nmol/L and median 67· 5 nmol/L). Plasma 250HD concentrations can change rapidly, to several-fold above their initial values, for instance after sunlight exposure." Such factors, rather than assay-reproducibility, determine the population sample-size requirements for surveys and for inter-group comparisons.
Reagent cost per sample is £20 for the Incstar kit, when used either according to the kit instructions, or with the minor modifications suggested by our work. In-house assays are likely to be cheaper in terms of reagents, but more expensive in terms of equipment and of trained laboratory staff. The kit requires a minimum of extra equipment (principally a centrifuge and gamma-counter) and a moderate degree of operator laboratory experience. A recent study from another laboratory" failed to reach a definitive conclusion about the accuracy of the Incstar 250HD kit assay, as compared with a competitive protein-binding assay. Further Ann cun Biochem 1995: 32 comparisons are therefore needed, using techniques such as GC-MS, so as to provide a 'gold standard' for comparison.
In conclusion, the Incstar kit seems capable of achieving a level of long-term precision that is required for survey work, provided that certain precautions are taken.
